Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

Bain Capital already owns nearly 40 percent of the Tennessee-based company’s stock. An analyst thinks other potential buyers ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Surgery Partners has received an acquisition offer the could take the public company private. Boston-based Bain Capital Partners has made an offer to purchase all outstanding shares of the company for ...

As multiple media reported, Bain Capital has proposed acquiring all outstanding Surgery Partners shares not already owned by ...

Private equity firm Bain Capital plans to fully acquire Surgery Partners, one of the five largest operators of ambulatory surgery centers, for $3.2 billion.

The planned 500-bed pediatric hospital will be somewhere in North Carolina's Research Triangle region, but no specific location has been announced. Other health industry news is on hospital-at-home ...

Bain Capital is making a play for full control of Surgery Partners (NASDAQ:SGRY), throwing down a $25.75 per share all-cash ...